The Future of CRISPR: Clinical Reality vs. Lab Ambition
A deep dive into the regulatory hurdles and venture capital landscape surrounding gene editing technologies in 2024. Exploration of Phase III successes.
Deep-dive conversations with global leaders at the intersection of clinical practice, venture capital, and breakthrough medical research. Precision insights for the modern physician-entrepreneur.
Clinical perspectives and market dispatches.
A deep dive into the regulatory hurdles and venture capital landscape surrounding gene editing technologies in 2024. Exploration of Phase III successes.
Discussing the ethics and implementation of predictive diagnostics in intensive care units with machine learning experts and clinical ethicists.
Real-world stories from clinicians who transitioned into the tech ecosystem and the unique challenges of scaling a health-tech venture from ground zero.
Get weekly summaries of every deep dive, plus bonus research papers and market analysis charts curated personally by Sri Harsha Soma.
"The only medical podcast that treats the business side of healthcare with the same rigor as the clinical side."